Achim Schneeberger

Summary

Publications

  1. ncbi request reprint Development of AFFITOPE vaccines for Alzheimer's disease (AD)--from concept to clinical testing
    A Schneeberger
    AFFiRiS, Viehmarktgasse 2A, A 1030 Vienna, Austria
    J Nutr Health Aging 13:264-7. 2009
  2. ncbi request reprint AFFITOME® technology in neurodegenerative diseases: the doubling advantage
    Achim Schneeberger
    AFFiRiS AG, Vienna, Austria
    Hum Vaccin 6:948-52. 2010
  3. doi request reprint Vaccination for Parkinson's disease
    A Schneeberger
    AFFiRiS AG, Karl Farkas Gasse 22, A 1030 Vienna, Austria
    Parkinsonism Relat Disord 18:S11-3. 2012

Detail Information

Publications3

  1. ncbi request reprint Development of AFFITOPE vaccines for Alzheimer's disease (AD)--from concept to clinical testing
    A Schneeberger
    AFFiRiS, Viehmarktgasse 2A, A 1030 Vienna, Austria
    J Nutr Health Aging 13:264-7. 2009
    ..Further clinical testing will focus on the identification of the optimal vaccine dose and immunization schedule. Together, result of these trials will provide a solid basis for clinical POC studies...
  2. ncbi request reprint AFFITOME® technology in neurodegenerative diseases: the doubling advantage
    Achim Schneeberger
    AFFiRiS AG, Vienna, Austria
    Hum Vaccin 6:948-52. 2010
    ....
  3. doi request reprint Vaccination for Parkinson's disease
    A Schneeberger
    AFFiRiS AG, Karl Farkas Gasse 22, A 1030 Vienna, Austria
    Parkinsonism Relat Disord 18:S11-3. 2012
    ..PD01, the first in class aSyn vaccine developed by AFFiRiS is about to enter the clinical phase of development...